Your browser doesn't support javascript.
loading
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Lustig, Yaniv; Gonen, Tal; Meltzer, Lilac; Gilboa, Mayan; Indenbaum, Victoria; Cohen, Carmit; Amit, Sharon; Jaber, Hanaa; Doolman, Ram; Asraf, Keren; Rubin, Carmit; Fluss, Ronen; Mendelson, Ella; Freedman, Laurence; Regev-Yochay, Gili; Kreiss, Yitshak.
Afiliação
  • Lustig Y; Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel HaShomer, Israel.
  • Gonen T; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Meltzer L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Gilboa M; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Indenbaum V; The Infection Prevention & Control Unit, Sheba Medical Center, Tel HaShomer, Israel.
  • Cohen C; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Amit S; The Infection Prevention & Control Unit, Sheba Medical Center, Tel HaShomer, Israel.
  • Jaber H; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel.
  • Doolman R; The Infection Prevention & Control Unit, Sheba Medical Center, Tel HaShomer, Israel.
  • Asraf K; Central Virology Laboratory, Public Health Services, Ministry of Health, Sheba Medical Center, Tel HaShomer, Israel.
  • Rubin C; The Infection Prevention & Control Unit, Sheba Medical Center, Tel HaShomer, Israel.
  • Fluss R; Clinical Microbiology, Sheba Medical Center, Tel HaShomer, Israel.
  • Mendelson E; The Infection Prevention & Control Unit, Sheba Medical Center, Tel HaShomer, Israel.
  • Freedman L; Automated Mega-Laboratory, Laboratory division, Sheba Medical Center, Tel HaShomer, Israel.
  • Regev-Yochay G; Automated Mega-Laboratory, Laboratory division, Sheba Medical Center, Tel HaShomer, Israel.
  • Kreiss Y; The Infection Prevention & Control Unit, Sheba Medical Center, Tel HaShomer, Israel.
Nat Immunol ; 23(6): 940-946, 2022 06.
Article em En | MEDLINE | ID: mdl-35534723

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel